NASDAQ:MESO
Mesoblast Ltd Stock News
$7.35
+0.330 (+4.70%)
At Close: May 17, 2024
New York, New York--(Newsfile Corp. - December 2, 2020) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Mesoblast Limited ("Mesoblast" or "th
Los Angeles, California--(Newsfile Corp. - December 2, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mesoblast Limi
FDA Grants Fast Track Designation for Remestemcel-L in the Treatment of Acute Respiratory Distress Syndrome Due to COVID-19
06:00am, Wednesday, 02'nd Dec 2020
NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the United States F
New York, New York--(Newsfile Corp. - December 1, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Mesoblast Limited (NASDAQ: MESO) between April 16,
Los Angeles, California--(Newsfile Corp. - December 1, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mesoblast Li
NEW YORK, Nov. 28, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Mesoblast Limited (NASDAQ: MESO) between April 16, 2019 and October 1
Where Do Hedge Funds Stand On Mesoblast Limited (MESO)?
01:07pm, Friday, 27'th Nov 2020
We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Se
New York, New York--(Newsfile Corp. - November 24, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
New York, New York--(Newsfile Corp. - November 23, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Mesoblast Limited (NASDAQ: MESO) alleg
New York, New York--(Newsfile Corp. - November 23, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
New York, New York--(Newsfile Corp. - November 20, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Mesoblast Limited (NASDAQ: MESO) between April 16,
Why Mesoblast Stock Is Blasting Off Today
11:20am, Friday, 20'th Nov 2020
Investors are excited about the biotech's new collaboration with Novartis.
Operational and Financial Results for the Period Ended September 30, 2020
05:36pm, Thursday, 19'th Nov 2020
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported operational and financial
Mesoblast Enters Global Collaboration for Development, Manufacture and Commercialization of Remestemcel-L
05:12pm, Thursday, 19'th Nov 2020
Initial Focus on Acute Respiratory Distress Syndrome, including COVID-19 Initial Focus on Acute Respiratory Distress Syndrome, including COVID-19
Mesoblast Corporate Update and Financial Results Webcast
04:19pm, Thursday, 19'th Nov 2020
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast today to provide a c
